Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs Journal Article


Authors: Pastores, S. M.; DeSancho, M. T.; Fowler, R. A.
Article Title: Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs
Keywords: note; cost control; drug cost; hospitalization; cardiovascular risk; heparin; health care system; low molecular weight heparin; venous thromboembolism; dalteparin; critically ill patient; randomized controlled trial (topic); clinical trial (topic); controlled clinical trial (topic); human; priority journal
Journal Title: Annals of Internal Medicine
Volume: 162
Issue: 6
ISSN: 0003-4819
Publisher: American College of Physicians  
Date Published: 2015-03-17
Start Page: JC13
Language: English
PROVIDER: scopus
PUBMED: 25775344
DOI: 10.7326/ACPJC-2015-162-6-013
DOI/URL:
Notes: Export Date: 2 April 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Pastores
    258 Pastores